Zhan W, An D, Lei J, Un H, et al. Evaluation of human epidermal growth factor receptor 2 (HER2)-related genes
revealed that HER2-antibody-drug conjugate (ADC) drugs confer clinical benefits
to Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle invasive bladder cancer
patients. Transl Androl Urol 2026;15:110.
PMID: 42164356
|